Laminin α1 expression is disrupted in the absence of Shh signalling. (A-E″) Whole-mount in situ hybridisation was performed on E9.5 wild-type (A,A′,C,C′), Shh-/- (B,B′,D,D′) and Shh-/-;Gli3-/- (E,E′,E″) mouse embryos using DIG-labelled RNA probes for Lama1 (A,B,E) and Lama5 (C,D). Laminin α1 (A″) and α5 (C″) were also detected by immunofluorescence. (A,A′) Lama1 expression in wild-type embryos. (A″) Laminin α1 immunodetection in wild-type interlimb somites. (B,B′) Lama1 expression in Shh-/- embryos. Transverse sections of newly-formed (inset in A and B) and interlimb (A′,B′) somites are shown. (B″) Laminin α1 immunodetection in Shh-/- interlimb somites. (C,C′) Lama5 expression in wild-type embryos. (C″) Laminin α5 immunodetection in wild-type interlimb somites. (D,D′) Lama5 expression in Shh-/- embryos. Transverse sections of interlimb somites (C′,D′) are shown. (D″) Laminin α5 immunodetection in wild-type interlimb somites. (E,E′,E″) Lama1 expression in Gli3-/-;Shh-/- embryos. The position of transverse sections shown in E′ and E″ is indicated. Yellow arrows and red asterisks show Lama1 expression in the pre-somitic mesoderm and newly-formed somites, respectively. Red arrows indicate sites of expression affected in the absence of Shh. Blue asterisks indicate Lama5 expression in newly formed somites, and blue arrowheads show dermomyotomal expression. s, sclerotome; dm, dermomyotome. Magnification: ×250 (A-E) and ×400 (A′-E′,A″-E″).